Clinical Trials Directory

Trials / Unknown

UnknownNCT04220424

Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis

Glioma Patients Registry Based on MR Images, Histopathology Images and Genetic Sequencing Analyzed by Artificial Intelligence

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
The First Affiliated Hospital of Zhengzhou University · Academic / Other
Sex
All
Age
1 Year – 95 Years
Healthy volunteers
Accepted

Summary

This prospective study aims to collect clinical, radiological, pathological, molecular and genetic data including detailed clinical parameters, MR and histopathology images, molecular pathology and genetic sequencing data. By leveraging artificial intelligence, this registry seeks to construct and refine algorithms that able to predict molecular pathology or clinical outcomes of glioma patients based on MR images and histopathology images, as well as revealing related mechanisms from genetic perspective.

Detailed description

Non-invasive and precise prediction for molecular biomarkers such as 1p/19q co-deletion, MGMT methylation, IDH and TERTp mutations, and patients survival is challenging for gliomas. With the development of artificial intelligence, much more potential lies in the preoperative conventional/advanced MR imaging (T1 weighted imaging, T2 weighted imaging, FLAIR, contrast-enhanced T1 weighted imaging, diffusion-weighted imaging, and perfusion imaging), and in the histopathology images of HE slices of gliomas could be excavated to aid prediction of molecular pathology and patients' survival of gliomas. This study aims to collect clinical, radiological, pathological, molecular and genetic data including detailed clinical parameters, MR and histopathology images, molecular pathology (1p/19q co-deletion, MGMT methylation, IDH and TERTp mutations, etc) and genetic data (Whole exome sequencing, RNA sequencing, proteomics, etc), and seeks to construct and refine algorithms that able to predict molecular pathology or clinical outcomes of glioma patients based on MR images and histopathology images, as well as revealing related mechanisms from genetic perspective.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMR and Histopathology images based prediction of molecular pathology and patient survivalMR and Histopathology images based prediction of molecular pathology and patient survival in gliomas by leverage artificial intelligence algorithms

Timeline

Start date
2018-11-01
Primary completion
2022-01-01
Completion
2022-03-01
First posted
2020-01-07
Last updated
2021-02-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04220424. Inclusion in this directory is not an endorsement.